DC
AERI

Diametric Capital’s Aerie Pharmaceuticals AERI Stock Holding History

Diametric Capital’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,573
Closed -$281K – 393
2022
Q3 		$281K Buy
+18,573
New +$216K 0.14% 186
2020
Q3 		– Sell
-21,759
Closed -$321K – 203
2020
Q2 		$321K Buy
21,759
+4,117
+23% +$60.9K 0.25% 99
2020
Q1 		$238K Sell
17,642
-14,715
-45% -$279K 0.29% 85
2019
Q4 		$782K Buy
+32,357
New +$670K 0.57% 73
2019
Q2 		– Sell
-5,873
Closed -$279K – 157
2019
Q1 		$279K Buy
+5,873
New +$259K 0.22% 84
2018
Q3 		– Sell
-29,629
Closed -$2M – 128
2018
Q2 		$2M Buy
29,629
+4,157
+16% +$233K 1.88% 21
2018
Q1 		$1.38M Buy
25,472
+18,419
+261% +$1.03M 1.05% 41
2017
Q4 		$421K Buy
+7,053
New +$428K 0.26% 93

Diametric Capital's AERI Position: Q4 2022 in Review

Diametric Capital sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 18,573 shares — an estimated $281K sold.

Diametric Capital first reported a position in AERI in Q4 2017 and held it in 8 quarters. The position peaked at $2M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Diametric Capital reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Diametric Capital sold 18,573 Aerie Pharmaceuticals shares in Q4 2022, an estimated $281K.
  • Diametric Capital first reported a position in Aerie Pharmaceuticals in Q4 2017 and held it in 8 quarters.
  • Diametric Capital's Aerie Pharmaceuticals position peaked at $2M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Diametric Capital's 13F filing for Q4 2022, filed 29 Mar 2023.